Embolus vs SHOT UK
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Embolus
This app provides clinical case studies and data interpretation exercises focused on laboratory haemostasis. It's designed to test and improve your knowledge for postgraduate Haematology exams and offers realistic patient and lab data.
- 70 clinical cases
- 6 key haemostasis areas
- Realistic patient data
- Lab data interpretation
- Exam question familiarization
- Progress tracking
Read full descriptionHide full description
Embolus originates from the popular website, Practical-Haemostasis.com, and is our second Haemostasis product. See sangmedicine.com for additional information. The app offers clinical cases and data interpretation exercises in laboratory haemostasis and is designed to both assess and reinforce your knowledge in this area and in addition to assist with your preparations for post-graduate examinations in Haematology. Embolus is intended for doctors in haematology training programmes, laboratory staff and anyone with an interest in laboratory haemostasis. #FEATURES# STUDY 70 different cases addressing 6 key areas of Haemostasis: - Screening Tests - Factor Assays - Genetic Tests - Platelet Function Tests - Thrombophilia Tests - Miscellaneous Tests EXPLORE realistic patient and laboratory data FAMILIARISE yourself with exam question format TRACK your progress and highlight areas that you feel require additional reading/review
SHOT UK
Read full descriptionHide full description
The mobile app for Serious Hazards of Transfusion (SHOT) Use the SHOT app to: • Learn about the latest developments in haemovigilance • Access all Annual SHOT Reports and SHOT resources • Access information about the Annual SHOT Symposium via the events programme, speakers, posters and more *Please note – the SHOT app cannot be used to make SHOT reports on SABRE/Dendrite* SHOT is the UK’s independent, professionally-led haemovigilance scheme. Since 1996 SHOT has been collecting and analysing anonymised information on adverse events and reactions in blood transfusion from all healthcare organisations that are involved in the transfusion of blood and blood components in the UK. Where risks and problems are identified, SHOT produces recommendations to improve patient safety. The recommendations are put into the Annual SHOT Report, which is circulated to all relevant organisations including the four UK Blood Services, the Departments of Health in England, Wales, Scotland and Northern Ireland; the relevant professional bodies and all reporting hospitals. The Annual SHOT Symposium brings together delegates from across the UK and beyond for the launch of the Annual SHOT Report and to share ideas, learn from peers and develop professional contacts. This one-day event includes presentations and debates on the hottest topics in transfusion safety, a poster competition, an abstract competition, and an opportunity for delegates to ‘Meet the Experts’ who help to make SHOT one of the world’s leading haemovigilance schemes.
Screenshots
Verdict
The clearest difference is in-app purchases: SHOT UK at none against Embolus's 8. SHOT UK also leads on iOS requirement (15.5 vs 18.0). Embolus's advantage is update cadence (every 2 months vs every 4 months). On price, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Embolus sells 8 one-off in-app purchases. SHOT UK asks for nothing beyond the download.
Embolus ships an update every 2 months, SHOT UK every 4 months. The most recent releases landed on September 7, 2026 and September 9, 2026 respectively.
| Parameter | Embolus | SHOT UK |
|---|---|---|
| Price | Free | Free |
| Rating | 4.7 (16 ratings) — better | — |
| Positive reviews | 71.4% of reviews | — |
| Number of ratings | 16 — better | — |
| Update frequency | Every 2 months — better | Every 4 months |
| Ads | No | No |
| In-app purchases | Yes | No — better |
| Monetization | Free with in-app purchases | — |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 18.0 | 15.5 — better |
| Further details — not scored | ||
| Size | 43 MB | 115 MB |
| Age rating | 17+ | 12+ |
| Developer | Sang Medicine Ltd | NHS |
In-app purchases
Embolus
- Screening Tests$1.99
- Factor Assays$1.99
- Platelet Function Tests$1.99
Show 5 moreShow fewer
- Genetic Tests$1.99
- Thrombophilia Tests$1.99
- Miscellaneous Tests$1.99
- Cloud Sync$1.99
- Haemostasis$9.99
SHOT UK
No in-app purchases









